FRANKFORT, Ky. — Kentucky Attorney General Jack Conway announced Friday that pharmaceutical company Pfizer Inc. has agreed to pay $14 million to settle allegations of illegal off-label marketing of its urology drug Detrol, according to a press release.
The settlement concludes a government investigation into the allegations that the company engaged in off-label marketing schemes to promote the sales of Detrol for uses that were not approved by the Food and Drug Administration (FDA).
The total value of the national civil settlement is $14 million, with $5,576,923 designated as Medicaid program recovery.
"I am pleased that a settlement has been reached and that we''ve been able to recover funds for a vital state program," General Conway said. "The illegal off-label marketing of drugs not only puts public health at risk, it takes millions of dollars out of taxpayers'' pockets."